Merit WRAPSODY™ Endoprothesis
Hemodialysis access failures take a great toll on a patient’s quality of life. Frequent hospital admissions, invasive diagnostic tests, and open and endovascular reinterventions are associated with increased morbidity.6 Maintaining vessel patency in hemodialysis patients is critical; however, surgical access durability is temporary at best, with half-life for arteriovenous grafts lasting approximately one year and arteriovenous fistulas providing only slightly better outcomes.6 A common failure of hemodialysis access is stenosis or occlusion of the dialysis outflow circuit. Obstructions caused by cellular migration and tissue accumulation across graft ePTFE layers can be a contributing factor.
Endoprosthesis Designed with Cell-Impermeable Middle Graft Layer – Merit WRAPSODYAddressing this clinical challenge, Merit Medical® introduced the Merit WRAPSODY™, a novel endoprosthesis designed with a revolutionary cell-impermeable middle graft layer. With this unique feature, the Merit WRAPSODY Endoprosthesis inhibits transmural cellular migration without the use of drug bonding, helping to prevent obstructions from forming within the endoprosthesis.
Key Features & Benefits
- Inhibits transmural cellular migration without the use of drug bonding
- Provides a viable treatment option that preserves functional hemodialysis access
- Biocompatible ePTFE material that allows for necessary tissue ingrowth to prevent stent migration